FSD Pharma Inc C.HUGE

Alternate Symbol(s): HUGE

Healthcare Cannabis

FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.

CSE:HUGE - Post by User

FSD Pharma Inc > No reverse splits or financings

<< Previous

Bullboard Posts

Next >>

Comment by Mil_Man54on Oct 06, 2022 2:34pm

72 Views

Post# 35010138

RE:No reverse splits or financings

What's wrong Rosenberg....does "reverse split" go against your pumping narrative....and why would you say it's a buzz word...."synergy" is a buzz word...."deep dive" is a buzz word....."retargeting" is a buzz word...."reverse split" is a noun....an actual course of action that will screw over investors again....and you should know the BoD is seriously considering it....since you work for them...